Cancer vaccine treatment led to increased activation of CD4+ and CD8+ T cells in the tumor regions of vaccinated mice, contributing to the antitumor effect. Moreover, cancer vaccine treatment exhibited an enhanced anticancer effect with anti-PD-L1 immunotherapy, in tumor-bearing mouse models. This evidence concerns the gene CD8A and neoplasm.